| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 26.03B | 27.97B | 26.43B | 24.67B | 21.55B | 24.59B |
| Gross Profit | 5.13B | 6.30B | 5.69B | 4.54B | 3.81B | 4.91B |
| EBITDA | 2.43B | 3.34B | 3.30B | 2.35B | 2.00B | 2.93B |
| Net Income | 1.70B | 2.26B | 2.31B | 1.55B | 999.00M | 1.97B |
Balance Sheet | ||||||
| Total Assets | 33.81B | 33.81B | 34.22B | 34.96B | 30.25B | 29.59B |
| Cash, Cash Equivalents and Short-Term Investments | 8.50B | 9.29B | 9.89B | 8.36B | 7.63B | 5.57B |
| Total Debt | 1.40B | 1.97B | 1.54B | 1.63B | 1.38B | 1.73B |
| Total Liabilities | 15.29B | 13.19B | 15.08B | 17.51B | 14.82B | 14.89B |
| Stockholders Equity | 18.52B | 20.62B | 19.13B | 17.45B | 15.42B | 14.69B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.53B | 2.11B | 790.00M | 2.81B | -360.00M |
| Operating Cash Flow | 0.00 | 2.53B | 2.58B | 1.01B | 3.41B | -214.00M |
| Investing Cash Flow | 0.00 | -1.97B | -427.00M | -234.00M | -589.00M | -150.00M |
| Financing Cash Flow | 0.00 | -1.16B | -612.00M | -79.00M | -770.00M | -518.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥40.00B | 19.17 | ― | 2.53% | 4.16% | 1.16% | |
72 Outperform | ¥174.67B | 10.51 | 10.28% | 2.77% | 4.61% | 1.98% | |
68 Neutral | ¥37.91B | 11.76 | ― | 3.32% | 17.04% | -5.21% | |
67 Neutral | ¥23.74B | 13.19 | ― | 3.34% | 5.83% | -1.27% | |
67 Neutral | ¥174.67B | 12.84 | 8.17% | 2.04% | 4.34% | 98.54% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥69.54B | 13.34 | ― | 3.09% | 7.43% | 47.68% |